Therefore, the CPVT-associated CaM variants N53I and A102V not only increase the RyR2 Po but also cause changes in Ca2+ release dynamics at a global cellular level, which will contribute to the arrhythmia phenotype. The gene discussed is CALM2; the disease is cardiac arrhythmia.